RESEARCH TRIANGLE PARK, N.C. - Fennec Pharmaceuticals (NASDAQ:FENC) Inc. (NASDAQ: FENC; TSX: FRX), a specialty pharmaceutical company with a market capitalization of $183 million, announced today that ...
Fennec Pharmaceuticals Inc., a specialty pharmaceutical company, announced that Norgine Pharmaceuticals Ltd., a leading European specialist pharmaceutical company, has commercially launched Pedmarqsi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback